• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[PD-1 inhibitor in chronic active Epstein-Barr virus infection: a report of six cases and literature review].

作者信息

Wu J Y, Xu B, Zhu X J, Ming X, Luo H, Mao X, Gu J, Zhou J F, Xiao Y

机构信息

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2023 Feb 14;44(2):165-168. doi: 10.3760/cma.j.issn.0253-2727.2023.02.016.

DOI:10.3760/cma.j.issn.0253-2727.2023.02.016
PMID:36948875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10033261/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7c/10033261/16cb2796bd7f/cjh-44-02-165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7c/10033261/16cb2796bd7f/cjh-44-02-165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c7c/10033261/16cb2796bd7f/cjh-44-02-165-g001.jpg

相似文献

1
[PD-1 inhibitor in chronic active Epstein-Barr virus infection: a report of six cases and literature review].[程序性死亡受体1抑制剂治疗慢性活动性EB病毒感染：6例报告及文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2023 Feb 14;44(2):165-168. doi: 10.3760/cma.j.issn.0253-2727.2023.02.016.
2
Outcomes of programmed death protein-1 inhibitors treatment of chronic active Epstein Barr virus infection: A single center retrospective analysis.程序性死亡蛋白-1 抑制剂治疗慢性活动性 Epstein-Barr 病毒感染的结果：一项单中心回顾性分析。
Front Immunol. 2023 Mar 10;14:1093719. doi: 10.3389/fimmu.2023.1093719. eCollection 2023.
3
Case report: Immune modulation after PD-1 inhibitor therapy in a patient with extranodal NK/T-cell lymphoma secondary to chronic active Epstein-Barr virus disease unveiled by single-cell transcriptomics.病例报告：单细胞转录组学揭示慢性活动性 EBV 病继发结外 NK/T 细胞淋巴瘤患者接受 PD-1 抑制剂治疗后的免疫调节
Front Immunol. 2023 Apr 17;14:1172307. doi: 10.3389/fimmu.2023.1172307. eCollection 2023.
4
Role of rapidly evolving immunotherapy in chronic active Epstein-Barr virus disease.快速发展的免疫疗法在慢性活动性EB病毒病中的作用
Front Immunol. 2024 Dec 3;15:1451977. doi: 10.3389/fimmu.2024.1451977. eCollection 2024.
5
Expression of Immune Checkpoint Regulators, Cytotoxic T-Lymphocyte Antigen-4, and Programmed Death-Ligand 1 in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.免疫检查点调节剂、细胞毒性 T 淋巴细胞抗原 4 和程序性死亡配体 1 在 Epstein-Barr 病毒相关鼻咽癌中的表达。
Appl Immunohistochem Mol Morphol. 2021 Jul 1;29(6):401-408. doi: 10.1097/PAI.0000000000000903.
6
Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.爱泼斯坦-巴尔病毒阳性和阴性浆母细胞淋巴瘤中的免疫检查点表达：82例患者的临床和病理研究
Haematologica. 2016 Aug;101(8):976-84. doi: 10.3324/haematol.2016.141978. Epub 2016 May 12.
7
Rescue of HLH with T and B Lymphocyte Involvement Due to Epstein-Barr Virus by PD-1 Inhibitor/Ruxolitinib and Rituximab Combination Regimens: A Case Report.PD-1 抑制剂/芦可替尼联合利妥昔单抗方案治疗 EBV 相关噬血细胞淋巴组织细胞增生症伴 T、B 淋巴细胞缺陷：1 例报告
Iran J Immunol. 2023 Dec 31;20(4):466-472. doi: 10.22034/iji.2023.99254.2629. Epub 2023 Oct 24.
8
A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.一种独特的 EBV 阳性 T/NK 细胞淋巴组织增生性疾病亚型：具有慢性活动性 EBV 感染样特征的成人患者。
Haematologica. 2018 Jun;103(6):1018-1028. doi: 10.3324/haematol.2017.174177. Epub 2017 Dec 14.
9
Immune checkpoint inhibitors are effective in the treatment of Epstein-Barr virus-associated gastric cancer: A case report.免疫检查点抑制剂在治疗 Epstein-Barr 病毒相关胃癌中的疗效：病例报告。
Medicine (Baltimore). 2023 Mar 31;102(13):e33377. doi: 10.1097/MD.0000000000033377.
10
Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.爱泼斯坦-巴尔病毒相关肝内胆管癌的临床病理特征、肿瘤免疫微环境及基因组格局
J Hepatol. 2021 Apr;74(4):838-849. doi: 10.1016/j.jhep.2020.10.037. Epub 2020 Nov 17.

引用本文的文献

1
TCR-T cell therapy for solid tumors: challenges and emerging solutions.用于实体瘤的TCR-T细胞疗法：挑战与新出现的解决方案
Front Pharmacol. 2025 Mar 10;16:1493346. doi: 10.3389/fphar.2025.1493346. eCollection 2025.

本文引用的文献

1
EBV Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of EBV-positive Hodgkin Lymphoma in Syria.EBV 血浆 Epstein-Barr 病毒 (EBV) DNA 作为诊断叙利亚 EBV 阳性霍奇金淋巴瘤的生物标志物。
J Infect Dev Ctries. 2021 Dec 31;15(12):1917-1922. doi: 10.3855/jidc.14919.
2
Ruxolitinib in Patients With Chronic Active Epstein-Barr Virus Infection: A Retrospective, Single-Center Study.鲁索替尼治疗慢性活动性EB病毒感染患者：一项回顾性单中心研究
Front Pharmacol. 2021 Sep 6;12:710400. doi: 10.3389/fphar.2021.710400. eCollection 2021.
3
EBV and the Pathogenesis of NK/T Cell Lymphoma.
爱泼斯坦-巴尔病毒与自然杀伤/T细胞淋巴瘤的发病机制
Cancers (Basel). 2021 Mar 19;13(6):1414. doi: 10.3390/cancers13061414.
4
Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.西妥昔单抗联合阿扎胞苷治疗复发难治性结外 NK/T 细胞淋巴瘤，鼻型：一例报告
Medicine (Baltimore). 2021 Mar 12;100(10):e24824. doi: 10.1097/MD.0000000000024824.
5
Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults.纳武利尤单抗治疗成人复发性/难治性 EBV 相关噬血细胞性淋巴组织细胞增生症。
Blood. 2020 Mar 12;135(11):826-833. doi: 10.1182/blood.2019003886.
6
Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma.PD-1/PD-L1 在肿瘤微环境和肿瘤细胞中表达对淋巴瘤的预后和临床病理意义。
Int Immunopharmacol. 2019 Dec;77:105999. doi: 10.1016/j.intimp.2019.105999. Epub 2019 Nov 6.
7
Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.T 细胞介导的针对 Epstein-Barr 病毒免疫的信号通路：来自遗传疾病的启示。
Immunol Rev. 2019 Sep;291(1):174-189. doi: 10.1111/imr.12791.
8
Prospective observation: Clinical utility of plasma Epstein-Barr virus DNA load in EBV-associated gastric carcinoma patients.前瞻性观察：血浆 EBV-DNA 载量在 EBV 相关胃癌患者中的临床应用。
Int J Cancer. 2020 Jan 1;146(1):272-280. doi: 10.1002/ijc.32490. Epub 2019 Jun 19.
9
Molecular pathogenic pathways in extranodal NK/T cell lymphoma.结外 NK/T 细胞淋巴瘤的分子发病机制。
J Hematol Oncol. 2019 Apr 2;12(1):33. doi: 10.1186/s13045-019-0716-7.
10
Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders.爱泼斯坦-巴尔病毒相关T/NK淋巴细胞增殖性疾病中的转录组异常
Front Pediatr. 2019 Jan 17;6:405. doi: 10.3389/fped.2018.00405. eCollection 2018.